Today, modern biotechs are moving compounds to the clinic at a faster pace than ever before. As a result, many companies struggle with the transition from an R&D culture to a more structured, regulated one. Some of their challenges include implementing regulated systems, policies and strategies. Crossing this chasm requires updating nearly everything from software to charts to documentation.
Register for this webinar to hear a detailed overview of process, data, personnel and cultural characteristics of clinical stage biotechs. The speakers will discuss key changes that are prompted by becoming a clinical-stage biotech, best practices for becoming GxP compliant, and how to mitigate the risks to data and quality.
Alok Tayi, PhD, Vice President of Life Sciences, Egnyte
Alok is the Vice President of Life Sciences at Egnyte where he is responsible for building and executing the company’s strategy for the life sciences market segment. Alok works across the organization to verticalize our marketing, sales, product, compliance and account management practices for this domain. Before joining Egnyte, Alok was a Y Combinator-backed entrepreneur and started two vertical software-as-a-service companies. Prior to his career in software, Alok spent over 15 years as a scientist: he took part in postdoctoral work at Harvard University with George Whitesides and has published papers in Nature and Nature Chemistry. Alok holds a PhD from Northwestern University and BS from Cornell University.Message Presenter
Octavian Boca, Sr. Principal Consultant, Massachusetts Technology Innovations
Our CEO and founder, Octavian Boca is Boston-based entrepreneur, that is passionate about technology, innovation and creative arts. He successfully founded few other businesses in the Life-Science strategic consulting space, information solutions and software development across US and EU. When he realized that technology was changing the arts and vice versa, he decided to take a new direction, and started Mass Technology Innovation.Message Presenter
Who Should Attend?
- Data Management
- Clinical Operations
- Regulatory Affairs
What You Will Learn
In this webinar, participants will learn:
- The key changes prompted by becoming a clinical stage biotech
- Best practices for becoming GxP compliant
- How to mitigate the risks to data and quality
Egnyte is the only secure content platform built specifically for business. With thousands of customers worldwide, in a variety of different vertical markets, Egnyte delivers secure content collaboration, compliant data protection and simple infrastructure modernization; all through a single SaaS platform. Founded in 2007, Egnyte is a privately held company with headquarters in Mountain View, CA, and offices in Raleigh, NC, Spokane, WA, London, and Poland. Investors include Google Ventures, Kleiner Perkins, Caufield & Byers, and Goldman Sachs.